Purchase Order 75N95023P00577

Award Date 9/26/23
Potential Completion Date 9/25/24
Potential Value $24K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Austria
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services, awarded a $22,990.00 firm-fixed-price purchase order to Inte:ligand Software-Entwicklungs- UND Consulting GMBH, an Austrian company, for the renewal of licenses to the company's LigandScout software suite. LigandScout provides molecular modeling and drug discovery informatics tools to support the agency's translational sciences programs. This is one of several...
This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the Department of Health and Human Services National Institutes of Health, to Inte:ligand Software-Entwicklungs- UND Consulting GmbH, an Austrian company. The $25,990.00 contract is for the one-year renewal of licenses to the company's LigandScout software suite, which provides molecular modeling and drug discovery informatics tools to support NCATS' translational...
The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $26,870 sole-source purchase order to Caerus US 1 Inc., operating as Citeline, to provide five one-year licenses for its Biomedtracker database and five one-year licenses for the Enhanced Company Deals Upgrade. These software tools will support NCATS' work on intellectual property issues, patent filing, and industry partnerships by providing access to a comprehensive...
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, awarded a $87,500.00 firm-fixed-price purchase order to Chemaxon LLC for a 5-year renewal and support of cheminformatics software licenses. The software, which includes products like JChem Oracle Cartridge, Marvin JS, and Instant JChem Enterprise, supports NCATS' initiatives in biotechnology and pharmaceutical research, such as the Preclinical Screening Platform...
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, awarded a $247,500 firm-fixed-price purchase order to Schrodinger, Inc. for X-ray crystallography (XRC) structure studies and surface plasmon resonance (SPR) studies. This requirement supports the agency's efforts to optimize compounds against bacterial enzymes. Schrodinger, Inc. is a for-profit organization that has previously received prime federal contracts...
<p>The National Center for Advancing Translational Sciences (NCATS), a civilian agency, awarded a $35,000.00 firm fixed price purchase order contract to Editco Bio Inc., a self-certified small disadvantaged business. The contract, with an ultimate completion date of December 17, 2024, is for the product SYNTHEGO:1293873 [24-007185]. The contract does not have a set-aside designation.</p>
This is a $447,635.80 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. government. The contract is for the &quot;SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)&quot; program and was awarded to Analyticon Discovery, LLC, a for-profit foreign-owned organization. The contract does not have a set-aside designation and has an ultimate completion date of January 31, 2016. NCATS is...
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, has awarded a $1,785,000.00 firm fixed price purchase order contract to X-Chem, Inc., a for-profit drug discovery company. The 8-month contract, which runs from May 2023 through January 2024, does not have a set-aside designation. Based on X-Chem's prior work as a subcontractor on federal grants focused on early-stage drug discovery research, the contract likely...
This is a firm-fixed-price purchase order for $149,960.58 awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Analyticon Discovery, LLC, a foreign-owned for-profit organization. The contract is set aside for small businesses and is part of the SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT) program. The contract is for the delivery of products and services related to small molecules for NCATS' pharmacologically active...
This federal contract award was issued by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract, valued at $42,500.00, was awarded to Adeptia Inc. for the provision of Adeptia Connect ETL (Extract, Transform, Load) data mapping software licenses and support services. The original solicitation was a non-competitive combined synopsis/solicitation for commercial...

The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, awarded a firm-fixed-price purchase order to Inte:ligand Software-Entwicklungs- UND Consulting GMBH, an Austrian company, for the renewal of licenses to the LigandScout software suite. The contract award value is $23,990.00 and has an ultimate completion date of September 25, 2024. LigandScout provides molecular modeling and drug discovery informatics tools to support NCATS' translational sciences programs. This award is not associated with any set-aside designation.

Generated 9/7/24, 10:38 AM